Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2022 | 05-2022 | 02-2022 | 11-2021 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -133,643 | -87,934 | -42,533 | -117,194 | -79,492 |
| Depreciation Amortization | 8,847 | 5,878 | 2,795 | 7,788 | 5,572 |
| Accounts receivable | 6,000 | 6,000 | N/A | -6,000 | 0 |
| Accounts payable and accrued liabilities | 984 | 1,747 | -103 | 1,589 | 727 |
| Other Working Capital | -17,100 | -6,544 | -8,963 | 9,113 | 9,381 |
| Other Operating Activity | 13,060 | 5,309 | 6,174 | 20,339 | 10,358 |
| Operating Cash Flow | $-121,852 | $-75,544 | $-42,630 | $-84,365 | $-53,454 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,679 | -6,261 | -3,472 | -5,661 | -4,799 |
| Purchase Of Investment | -212,455 | -80,031 | -15,245 | -348,497 | -257,813 |
| Sale Of Investment | 194,324 | 121,558 | 58,748 | 245,907 | 190,884 |
| Investing Cash Flow | $-27,810 | $35,266 | $40,031 | $-108,251 | $-71,728 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22,385 | 1,920 | 1,488 | 153,883 | 153,383 |
| Common Stock Repurchased | N/A | N/A | N/A | -1 | -1 |
| Other Financing Activity | 94,942 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $117,327 | $1,920 | $1,488 | $153,882 | $153,382 |
| Beginning Cash Position | 80,792 | 80,792 | 80,792 | 119,526 | 119,526 |
| End Cash Position | 48,457 | 42,434 | 79,681 | 80,792 | 147,726 |
| Net Cash Flow | $-32,335 | $-38,358 | $-1,111 | $-38,734 | $28,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,852 | -75,544 | -42,630 | -84,365 | -53,454 |
| Capital Expenditure | -9,679 | -6,261 | -3,472 | -5,661 | -4,799 |
| Free Cash Flow | -131,531 | -81,805 | -46,102 | -90,026 | -58,253 |